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Abstract
Background: The aim of the present study was to gain national data on the clinical and microbiological
characteristics of community-acquired infections in the Faroe Islands and to compare these data with data from
other geographical areas.
Methods: A prospective, observational study involving all patients > = 16 years admitted at the Department of
Medicine at the National Hospital, Torshavn, Faroe Islands from October 2013 until April 2015.
Results: Of 5279 admissions, 1054 cases were with community-acquired infection and were included in the study.
Out of these 1054 cases, 471 did not meet the criteria for SIRS (Systemic Inflammatory Response Syndrome), while
the remaining 583 cases had sepsis. Mean age was 68 years. At least one comorbidity was found in 80% of all cases.
Documented infections were present in 75%, and a plausible pathogen was identified in 29% of all cases. The most
common gram-positive pathogen was Staphylococcus aureus, and the most frequent gram-negative pathogen was
Escherichia coli. The most common focus of infection was lower respiratory tract, followed by urinary tract, and skin-
soft tissue/bone-joint. Bacteremia was found in 10% of the cases.
Conclusion: In community-acquired infections in hospitalized patients in the Faroe Islands the lower respiratory
tract and the urinary tract were the most frequent foci of infection. Gram-negative pathogens and Escherichia coli
were the most frequent pathogens in infection without Systemic Inflammatory Response Syndrome, in sepsis and
in bacteremia. Our data on clinical characteristics and microbiological etiology provide new information which may
be used to develop local guidelines for the managing of patients admitted with community-acquired infections.
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Background
Infections carry significant morbidity and mortality
worldwide [1, 2]. Extensive research has been done in re-
lation to infections among patients admitted to hospital,
but often the focus has been on more severe forms of in-
fection, or on specific sites such as pneumonia or urin-
ary tract infections. According to de Prost et al. only
40–60% of severe sepsis or septic shock cases have a
microbiologically confirmed infection [3]. These authors
argue that this is due to antibiotic therapy received prior
to the onset of organ dysfunction, insufficient or incom-
plete diagnostic workup, or the presence of unusual
organisms that are difficult to identify in routine
practice. Some infections have even lower percentage of
microbiological confirmation [4–7].
The progression from onset of infection to sepsis can
be insidious and unpredictable [8]. Therefore, proper
diagnosis and treatment in the early stages of infections
are essential to the outcome [9].
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The pattern of infectious diseases may vary from
country to country. Therefore, regional research regarding
different aspects of community-acquired infection such as
incidence, microbial etiology and focus of infection is es-
sential for understanding the burden of infection locally in
community, and for developing regional and national
strategies for diagnosing and treating infectious diseases.
Although research has been done on specific infections in
the Faroe Islands, no studies have been done describing
the general characteristics of community-acquired
infections in the country. The aim of the present study
was to gain data on the clinical characteristics of
community-acquired infections in the Faroe Islands at the
present time, and to compare these data with data from
other geographical areas.
Methods
Study design and setting
This study is based on a prospective observational epi-
demiological study on sepsis in medical patients in the
Faroe Islands. A previous publication on the epidemio-
logical aspects of this cohort has been published [10].
More detailed information on the methodology is pre-
sented in the previous published paper [10]. In short, all
medical patients admitted at the Department of
Medicine at the National Hospital of the Faroe Islands
were included in the study in the period from October
1st, 2013 to April 1st, 2015 [10]. The National Hospital
of the Faroe Islands is the central hospital in the coun-
try, serving 37870 inhabitants in its catchment area in
the study period [11]. This corresponds to 80% of the
population of the Faroe Islands [11]. All medical adult
patients admitted at the Department of Medicine at the
National Hospital of the Faroe Islands in the study
period were included in the study [10].
Patient selection
All medical patients > = 16 years of age admitted at the
Department of Medicine or at the Intensive Care Unit at
the National Hospital of the Faroe Islands in the study
period were included.
All included patients were investigated in detail
regarding signs and symptoms of infection occurring
within the first 48 h of admission [10]. Patients with
hospital-acquired infections were excluded from the study
[10]. Patients transferred to the Department of Medicine
either from surgical departments or from two other
Faroese hospitals were also excluded from the study [10].
All data were collected in a prospective manner. Vital
signs and laboratory data were collected in the first 48 h
of admission. Patients were classified in a group of
infected patients and in a group of patients without
infection by using pre-study defined consensus criteria
(Additional file 1). The focus of infection was
characterized and the Systemic Inflammatory Response
Syndrome (SIRS) criteria were used for the sepsis classi-
fication [12]. Sepsis severity was characterized with the
Sepsis-related Organ Failure Assessment (SOFA) Score
with oxygen saturation as a variable for respiratory
failure [13] (Appendix 1).
Results from blood cultures and other microbiological
specimens (cerebrospinal fluid, sputum/secretions from the
respiratory tract, urine, abscess drainage, feces) were regis-
tered from all included patients. Only samples obtained in
the first 48 h of admission were used. Blood cultures were
done using two aerobic and two anaerobic bottles (BD
BACTEC, Benex Limited, Dun Laoghaire, Ireland). Blood
cultures with possible contamination were excluded from
the analysis. Coagulase-negative staphylococci, Corynebac-
terium spp., Proprionibacterium acnes, and Bacillus spp.
were considered as contaminants unless they were isolated
from two or more separate blood-culture sets [14].
The microbiological analyses were done locally at our
Laboratory of Clinical Microbiology at the National
Hospital of the Faroe Islands. Our laboratory uses standard
methods for pathogen identification and resistance testing
(EUCAST) used in Scandinavia and in the Nordic coun-
tries. More specialized analyses and confirmatory tests
were done at the National Reference Laboratory of Clinical
Microbiology in Denmark (SSI, Statens Serum Institut,
Copenhagen, Denmark, https://www.ssi.dk/). Our Labora-
tory of Clinical Microbiology at the National Hospital of
the Faroe Islands is supervised, and quality controlled by
SSI in Copenhagen.
Information regarding the presence of co-morbidity in
each single included infected patient was obtained from
the electronic patient records. The Charlson comorbidity
index was calculated in each patient [15].
Definitions
Community-acquired infection was defined as an infection
contracted outside of a health care facility or an infection
present at the time of admission.
Infection was defined as the presence of a clinically rele-
vant pathogen by microscopy/culture/polymerase chain re-
action, positive serology result, pneumonia verified by
chest-X ray, infection documented with other imaging
techniques, positive urine dip test combined with symp-
toms of urinary tract infection, or as typical clinical symp-
toms such as for example erysipelas [16] (Additional file 1).
Systemic Inflammatory Response Syndrome (SIRS)
was defined according to the consensus conference from
1992 [12].
Sepsis was defined as the presence of SIRS and a docu-
mented or suspected infection.
Severe sepsis was defined with the presence of at least
one of the findings presented in Appendix 2.
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Septic shock was defined as sepsis with persistent sep-
sis induced hypotension for more than one hour despite
adequate fluid resuscitation.
Bacteremia was categorized as community-acquired if
there were clinical evidence that the infection was present
or incubating when the patient was admitted [17].
The study was planned in 2012 when the SIRS criteria
were the official criteria used in sepsis studies [12]. The new
Sepsis-3 criteria were published in 2016 [9]. Because the
study was planned before 2016 we decided to follow our re-
search protocol using the SIRS criteria to define sepsis.
Data analyses
Descriptive statistics were used to summarize the demo-
graphics and characteristics of 1054 cases eligible for the
analysis. Results are expressed as mean ± standard devi-
ation and as frequencies and percentages. Significance
testing between groups was performed using Chi square
tests. Database management and calculation of descrip-
tive statistics were performed using Access and Excel
(Microsoft Corporation, Redmond, Washington).
Ethical considerations
The Faroese Ethical Committee assessed that our study did
not need approval according to Faroese law as it was regis-
ter based. The study was approved by The Faroese Data
Protection Agency (J. no: 13/00082–4). Gathered data were
anonymized and kept on the hospital’s safe server.
Results
During the 18months of prospective data collection, we
recorded a total of 5279 admissions. Adult patients
(age > = 16 years) accounted for 3615 admissions.
Among these, 1054 patient admissions were associated
with community-acquired infections, and these admis-
sions were included as cases in the study. In 471 (45%)
cases patients did not meet the SIRS criteria, while the
remaining 583 (55%) met the definition of sepsis (Fig. 1).
Of the total study population (patients with infection),
men were admitted 515 times and women 539 times.
Mean age was 68 years (ranged in age from 16 to 102
years). At least one comorbidity was reported in 839
cases (80% of all cases with infection). The most com-
mon comorbidities were diabetes, chronic pulmonary
disease, myocardial infarction, connective tissue diseases,
cerebrovascular disease, and metastatic solid tumors.
Demographic data on our study population, distribution
of SIRS, qSOFA, primary sites of infection, and organ
dysfunction are presented in Tables 1 and 2.
Infections were radiologically and/or microbiologically
confirmed in 780 (74%) of all cases; a plausible pathogen
was identified in 304 cases (29%). Table 3 shows the
breakdown of specific pathogens. A causative pathogen
was identified in 169 cases (36%) of infection without
SIRS, 120 cases (41%) of sepsis, 140 cases (53%) of se-
vere sepsis and 13 cases (62%) of septic shock.
Among gram-positive microorganisms Staphylococcus
aureus was found in 71 cases (16% of all positive tests)
and Streptococcus pneumoniae in 30 cases (7% of all
positive tests). As for gram-negative microorganisms
Escherichia coli accounted for almost one-third of the
isolates (130 cases – 30% of all positive tests). Anaerobes
were isolated in 10 cases (2% of all positive tests). Fungal
infection due to Candida spp. were found in 7 (1.6% of
all positive tests) cases. There were 3 cases (0.7% of all
positive tests) with ESBL (all Escherichia coli), found in
urine in patients with urinary tract infections.
Haemophilus influenzae was the most common patho-
gen found in cases with lower respiratory tract infec-
tions, followed by Streptococcus pneumoniae. The most
frequent pathogen in urinary tract infections was Escher-
ichia coli. The most common pathogen in skin-soft tis-
sue infections was Staphylococcus aureus.
By site of infection, the most common focus of infec-
tion was lower respiratory tract (407 cases, 39% of all in-
fections), urinary tract (204 cases, 19% of all infections),
followed by the skin, soft tissue, and bones (99 cases, 9%
of all infections). These three major sites accounted for
more than 67% of all sources of infection. Two or more
sites were involved in 87 cases (8% of all infections) of
community-acquired infections. Women were admitted
with bronchitis and urinary tract infections more often,
while men had more catheter related infections. The pri-
mary focus of infection was unknown in 274 cases (26%
of all infections).
In 427 cases (40% of all cases with infection) the focus
of infection was found by imaging techniques, in 275
cases (26% of all cases with infection) by finding the re-
sponsible pathogen, and in 29 cases (2.8% of all cases
with infection) by both. Of all radiological analyses with
positive radiological findings suggesting infection 87%
were chest x-rays. In 58 cases (6% of all cases with infec-
tion) no microbiological analyses were performed. In 27
cases (3% of all cases with infection) neither microbio-
logical analyses nor imaging or other diagnostic methods
were performed. In this group 4 cases were treated for
recurrent, previously diagnosed infections, 6 were diag-
nosed by examining the patients clinically, and in 16
cases infection diagnosis remained uncertain.
Positive blood cultures were found in 99 cases (Table 4).
Twelve cases had bacteremia without SIRS. In 76 patients
a single bacteremia episode was found whereas 10 patients
experienced multiple episodes of bacteremia. Of those pa-
tients, 8 had repeatedly positive blood cultures with the
same pathogen, most commonly Staphylococcus aureus
(10 episodes in 4 patients) and Escherichia coli (7 episodes
in 3 patients). Two other patients had consecutive
episodes of bacteremia with different species. The most
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frequent pathogens involved in the bacteremia were:
Escherichia coli (47%), Staphylococcus aureus (19%) and
Klebsiella spp. (12%). Bacteremia was more frequent in
patients with diabetes (20/86 patients (23%)) and connect-
ive tissue disease (18/86 patients (21%)) in men (47
patients (55%)), and older population (mean age 70).
There were 18 cases (18%) of patients with cancer who
had positive blood cultures. The use of immunosuppres-
sive medications was found in 25 patients or in 29 cases
(29%) with bloodstream infections.
By site of infection, most patients with bacteremia had
either pneumonia or urinary tract infections.
Discussion
Principal findings
Infection was documented in 74% of the patients. The
most common focus of infection was lower respiratory
tract infection, followed by urinary tract infection and
skin-soft tissue/bone-joint infections. Gram-negative path-
ogens, especially Escherichia coli, predominated. The most
frequent pathogen was Haemophilus influenzae in lower
respiratory tract infections, Escherichia coli in urinary
tract infections and Staphylococcus aureus in skin-soft tis-
sue infections. In the group with bacteremia urinary tract
and lower respiratory tract foci predominated. Among
those with bacteremia, Escherichia coli and Staphylococcus
aureus were the most frequent pathogens.
Comparison to other studies
Community-acquired infections
To the best of our knowledge there are very few studies
on hospitalized patients with community-acquired infec-
tion of any severity and with different foci of infection.
Most of existent studies focus either on more severe
Fig. 1 Flow diagram of enrolled patients
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forms of infection, mostly severe sepsis and septic shock
[18–20]; on particular infections such as pneumonia
[21, 22], urinary tract infections [23, 24]; on a specific
pathogen [25]; on specific aspect like antibiotic consump-
tion [26], or on specific gender/gender dependent differ-
ences [27, 28]. According to Alberti et al. differences in
studies´ definitions and population make it difficult, and to
compare their findings [29]. This is why we used “infectio-
n-approach” focusing on infection rather than only on
sepsis, and analyzing data associated with community-ac-
quired infections of any severity in adults. To our
knowledge the only study addressing similar aspects of
community-acquired infection/sepsis was the Danish study
by Ostrowski et al. [30].
Microbiology
We found that gram-negative infections were docu-
mented in more than a half of the cases with identified
pathogen. This is similar to the study by Henriksen at al.
[31]. Flaatten et al. found gram-negative pathogens in
57% of cases in the study population that consisted of
both community-acquired and hospital-acquired infec-
tions [32]. Søgaard et al. found gram-negative pathogens
in 51% of cases with bloodstream infections [33]. Martin
et al. showed predominance of gram-positive pathogens
[34]. The EPIC II study analyzed surgical and medical
patients admitted to the Intensive Care Unit with both
community-acquired infection and hospital-acquired in-
fections, and found more gram-negative pathogens [35].
Predominance of gram-positive pathogens in the blood
were found in studies by the SepNet Critical Care Trials
Group and Karlsson [20, 36]. Vincent et al. found almost
equal rate of gram-positive and gram-negative bacteria,
with slight predominance of gram-positive pathogens in
their study of medical and surgical patients with sepsis
admitted in 198 Intensive Care Units in 24 European
countries [37], and similar results were found in two
Spanish studies from Blanco et al. [38] and Esteban et al.
[39]. Sands found that 40% of all episodes with sepsis
syndrome had gram-negative pathogens (Enterobacteria-
ceae) [40]. In this study gram-negative pathogens were
mostly found in all sepsis syndrome cases with exclusion
of cases with bacteremia, where gram-positive pathogens
were mostly found, with Staphylococcus aureus as the
most frequent. Escherichia coli, Klebsiella spp. and
Staphylococcus aureus were the most frequent pathogens
in a Korean study of medical and surgical patients ad-
mitted to the Emergency Department and Intensive Care
Units by Park et al. [41]. In a Columbian study Rodrí-
guez at al. showed that Escherichia coli, Staphylococcus
aureus and Klebsiella spp. were the most frequent path-
ogens found in the blood as shown in our study [42].
Focus of infection
The most frequent focus of infection in our study, in all
groups, were lower respiratory tract, urinary tract and
skin-soft tissue/bone-joint infections, which is consistent
with other studies focusing on community-acquired in-
fections [30, 31, 42, 43]. Lower respiratory tract infec-
tions were the focus in almost 50% of all infections
Table 1 Demographic characteristics of patients admitted at the Department of Medicine with infection without SIRS, sepsis, severe
sepsis and septic shock in an 18-month period
Variables Infection without SIRS Sepsis of any severity Sepsis Severe sepsis Septic shock
Total n = 471 n = 583 n = 296 n = 266 n = 21
Gender, n (%)
Male 217 (46.1) 298 (51.1) 141 (47.6) 145 (54.5) 12 (57.1)
Female 254 (53.9) 285 (48.9) 155 (52.4) 121 (45.5) 9 (42.9)
Age categories, yrs., n (%)
15–39 50 (10.6) 56 (9.6) 44 (14.9) 11 (4.1) 1 (4.8)
40–64 92 (19.5) 142 (24.4) 68 (23.0) 69 (25.9) 5 (23.8)
65–84 241 (51.2) 291 (49.9) 159 (53.7) 124 (46.6) 8 (38.1)
85+ 88 (18.7) 94 (16.1) 25 (8.4) 62 (23.3) 7 (33.3)
Charlson comorbidity index, n (%)
0 92 (19.5) 123 (21.1) 68 (23.0) 51 (19.2) 4 (19.0)
1–2 176 (37.4) 213 (36.5) 104 (35.1) 102 (38.3) 7 (33.3)
> 2 203 (43.1) 247 (42.4) 124 (41.9) 113 (42.5) 10 (47.6)
Immunosuppression*, n (%)
No 282 (59.9) 389 (66.7) 182 (61.5) 190 (71.4) 17 (81.0)
Yes 189 (40.1) 194 (33.3) 114 (38.5) 76 (28.6) 4 (19.0)
*Immuno-compromised state was defined by either administration in the 6 months prior to admission of steroid treatment (at least 0.3 mg/kg prednisolone),
radiation therapy, chemotherapy, or as severe malnutrition, congenital immuno- humoral or cellular immune deficiency state [29]
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Table 2 Distribution of systematic inflammatory response syndrome, infections and organ dysfunction in patients admitted at the
Department of Medicine with infection without SIRS, sepsis, severe sepsis and septic shock in an 18-month period
Variables Infection without SIRS Sepsis of any severity Sepsis Severe sepsis Septic shock
Total n = 471 n = 583 n = 296 n = 266 n = 21
Bacteremia, n (%)
No 459 (97.5) 496 (85.1) 265 (89.5) 216 (81.2) 15 (71.4)
Yes 12 (2.5) 87 (14.9) 31 (10.5) 50 (18.8) 6 (28.6)
No. of sources of infection per patient, n (%)
1 318 (67.5) 380 (65.2) 184 (62.2) 183 (68.8) 13 (62.0)
2 21 (4.5) 57 (9.8) 19 (6.4) 35 (13.2) 3 (14.3)
3 1 (0.2) 3 (0.5) 0 3 (1.1) 0
Sites of infection, n (%)*
CNS 1 (0.2) 3 (0.5) 1 (0.3) 2 (0.8) 0
Upper respiratory tract 7 (1.5) 7 (1.2) 3 (1.0) 4 (1.5) 0
Lower respiratory tract 162 (34.4) 245 (42.0) 107 (36.1) 129 (48.5) 9 (43.0)
Cardiovascular 3 (0.6) 1 (0.2) 1 (0.3) 0 0
Abdominal 15 (3.2) 16 (2.7) 5 (1.7) 9 (3.4) 2 (9.5)
Genitourinary tract 89 (18.9) 119 (20.4) 60 (20.3) 57 (21.4) 2 (9.5)
Skin-soft tissue/bone-joint 49 (10.4) 50 (8.6) 26 (8.8) 23 (8.6) 1 (4.8)
Catheter infection 15 (3.2) 31 (5.3) 6 (2.0) 22 (8.3) 3 (14.3)
Other infection 23 (4.9) 29 (5.0) 13 (4.4) 14 (5.3) 2 (9.5)
Uncertain group with bacteremia 0 10 (1.7) 5 (1.7) 5 (1.9) 0
Uncertain group without bacteremia 131 (27.8) 133 (22.8) 88 (29.7) 40 (15.0) 5 (23.8)
SIRS, n (%)
Pulse rate 149 (31.6) 406 (69.6) 216 (73.0) 177 (66.5) 13 (61.9)
Temperature 75 (15.9) 296 (50.8) 164 (55.4) 126 (47.4) 6 (28.6)
Respiratory rate 12 (2.5) 427 (73.2) 211 (71.3) 198 (74.4) 18 (85.7)
Leukocyte count 73 (15.5) 368 (63.1) 187 (63.2) 170 (63.9) 11 (52.4)
SOFA positive criteria, n (%)
0 183 (38.9) 148 (25.4) 131 (44.3) 17 (6.4) 0
1 181 (38.4) 183 (31.4) 115 (38.9) 68 (25.6) 0
2 53 (11.3) 126 (21.6) 40 (13.5) 83 (31.2) 3 (14.3)
3+ 54 (11.5) 126 (21.6) 10 (3.4) 98 (36.8) 18 (85.7)
SIRS positive criteria, n (%)
2 0 342 (58.7) 190 (64.2) 143 (53.8) 9 (42.9)
3 0 203 (34.8) 101 (34.1) 93 (35.0) 9 (42.9)
4 0 38 (6.5) 5 (1.7) 30 (11.3) 3 (14.3)
QSOFA, n (%)
0 325 (69.0) 245 (42.0) 213 (72.0) 32 (12.0) 0
1 126 (26.8) 235 (40.3) 79 (26.7) 149 (56.0) 7 (33.3)
2 19 (4.0) 74 (12.7) 4 (1.4) 64 (24.1) 6 (28.6)
3 1 (0.2) 29 (5.0) 0 21 (7.9) 8 (38.1)
*The added number of individual sites of infection exceed the number of patients because one patient could have more than one site of infection or organ failure
associated with the admission
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among patients with severe sepsis or septic shock. This
too is consistent with the study by Ostrowski et al. and
Henriksen et al. [30, 31]. We found that only 3% of cases
had an abdominal focus of infection, probably reflecting
that our study did not include patients admitted to the
Surgical Department. Other studies showed higher per-
centage of abdominal infections [20, 26, 29, 31, 37, 38].
All these studies, with exception of the first, involved
surgical patients and/or patients with hospital-acquired
infection.
We could not determine the focus of infection in 26% of
the cases with clinical infection according to our study
entry criteria. In the group of sepsis of any severity 25% of
cases had undetermined focus of infection. Wang et al.
showed that 17% of their cases with community-acquired
sepsis were undetermined, with extra 2% of cases with
Table 3 Microbiological etiology in community-acquired infection
Microorganism Infection without SIRS Sepsis Severe sepsis Septic shock
Gram-positive
Streptococcus pneumoniae 12 9 7 2
Group A/C/G streptococci 8 6 11 1
Group B streptococci 1 4 2 0
Enterococci 2 1 2 0
Staphylococcus aureus 25 19 25 2
Coagulase negative Staphylococcus 7 2 1 1
Staphylococcus lugdunensis 1 0 0 0
Staphylococcus epidermidis 3 4 2 0
Staphylococcus saprophyticus 1 0 0 0
Non haemolytic streptococcus 0 1 1 0
Gram-negative
Escherichia coli 46 44 37 3
ESBL - Escherichia coli 1 0 2 0
Klebsiella spp. 12 8 7 0
Other Enterobacteriaceae 9 2 8 1
Moraxella catarrhalis 6 1 4 1
Pseudomonas aeruginosa 4 3 4 0
Haemophilus spp. 16 9 10 1
Campylobacter spp. 1 0 0
Legionella spp. 0 0 4 0
Unspecified gram-negative rods 4 1 4 0
Anaerobic bacteria
Clostridium spp. 2 0 4 0
Bacteroides spp. 0 0 0 0
Unspecified gram-positive rods 2 1 1 0
Other
Mycoplasma pneumoniae 1 2 0 0
Mycobacterium tuberculosis 0 1 0 0
Candida spp. 4 1 1 1
H1N1 0 0 1 0
Herpesvirus 1 0 0 0
Sapovirus 0 1 0 0
VZV 0 0 1 0
Norovirus 0 0 1 0
*The added number of pathogens exceeds the number of cases because one patient could have more than one pathogen found in obtained cultures
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fever of unknown origin [44]. The occurrence of undeter-
mined infection foci will be discussed in the study limita-
tion section of this article.
Strengths
This is the first study on etiology and focus of infection
in the context of community-acquired infections requir-
ing hospitalization in the Faroe Islands. This is a pro-
spective, observational study conducted during a period
of 18 months. In many circumstances observational data
provide the only evidence to guide future management
[45]. Our study probably describes a more accurate
real-life picture of the infectious diseases panorama
among hospitalized patients with community-acquired
infections.
Limitations
This study included only patients admitted and treated
at the Department of Medicine and medical patients ad-
mitted at the Intensive Care Unit at the National Hos-
pital of the Faroe Islands, thus not making this a
nation-wide study. However, according to our experi-
ence, most patients with community-acquired infections
are admitted at the Department of Medicine and accord-
ing to Statistics Faroe Islands (Hagstova Føroya) [11],
the National hospital of the Faroe Islands has a catch-
ment area of 80% which could argue that we showed
nationally representative data. Another limitation of
the study is that it is likely that some patients with
abdominal and gynecological focus of infection would
be diagnosed and treated at the Surgical Department
of the hospital. This selection bias would underesti-
mate the frequency of abdominal, gynecological and
other surgical infections. Another limitation is that
we may have underestimated the number of patients
with community-acquired infection as some patients
admitted with noninfectious diseases had an infection
at the time of admission. These patients were not
always fully investigated for infection in the first 48 h.
The focus of infection or a plausible pathogen was
not identified in all patients. An explanation could be
that some patients were already in antibiotic treat-
ment prior to hospitalization and diagnostic sampling.
This, according to other studies, can influence the
diagnostic processes [46]. Even though we found that
in most cases proper diagnostic tests were done, diag-
nostic workup may have been insufficient or incom-
plete in some cases since all decisions concerning
diagnostics and treatment were up to the treating
physician. This may also have contributed to the
number of cases with unidentified focus and lack of
proven microbiological etiology.
Conclusion
This is the first study done in the Faroe Islands focusing
on etiology and focus of infection in patients with
community-acquired infections requiring hospitalization.
The lower respiratory tract and urinary tract were the
most site of infection. The most common etiologic
agents were gram-negative pathogens.
Table 4 Cases with bloodstream infection related to infection severity
Microorganism Infection without SIRS Sepsis Severe sepsis Septic shock
Gram-positive
Streptococcus pneumoniae 1 1 3 2
Group A/C/G streptococci 0 0 2 1
Group B streptococci 0 1 2 0
Enterococcus spp. 0 0 2 0
Staphylococcus aureus 2 4 13 0
Staphylococcus lugdunensis 1 0 0 0
Staphylococcus epidermidis 0 2 2 0
Non haemolytic streptococcus 0 1 1 0
Gram-negative
Escherichia coli 5 22 17 3
Klebsiella spp. 2 4 6 0
Other Enterobacteriaceae 0 0 2 0
Pseudomonas aeruginosa 1 0 0 0
Haemophilus spp. 0 0 1 0
Anaerobic bacteria
Clostridium spp. 0 0 1 0
*The added number of pathogens exceeds the number of cases because one patient could have more than one pathogen found in blood cultures
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Appendix 2
Organ dysfunction criteria:
(1).Glasgow coma scale of less than or equal to 14
(2). PaO2 of less than or equal to 9,75 kPa
(3).Oxygen saturation of less than or equal to 92%
(4). PaO2/FiO2 of less than or equal to 250
(5). Systolic blood pressure of less than or equal to
90 mmHg
(6). Systolic blood pressure decrease of more than
or equal to 40 mmHg
(7). pH of less than or equal to 7,3
(8). Lactate of more than or equal to 2,5 mmol/l
(9).Creatinine of more than or equal to 177 μmol/l
(10).100% increase of creatinine in patients with known
kidney disease
(11).Oliguria of less than or equal to 30 ml/h in more
than 3 h or less than or equal to 0,7 l/24 h
(12).International normalized ratio of higher
than or equal to 1,5
(13).Platelets of less than or equal to 100x10π/l
(14).Bilirubin of more than or equal to 43 μmol/l
(15).Paralytic ileus
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Appendix 1
Table 5 Modified SOFA score
Organ system Variable 0 1 2 3 4
Respiratory PaO2/FiO2 or O2 saturation ≥400 or ≥ 98% < 400 or 97–90% < 300 or 89–80% < 200 with respiratory
support or < 79%
< 100 with respiratory
support
Coagulation Platelets (109/l) ≥150 < 150 < 100 < 50 < 20
Liver Bilirubin (μmol/l) < 20 20–32 33–101 102–204 > 204
Cardiovascular Hypotension ≤70 ≤70 fluid only ≤70* ≤70** ≤70***
Brain Glasgow Coma Scale 15≤ 13 and 14 10–12 6–9 < 6
Kidney Creatinine (μmol/l) < 110 110–170 171–299 300–440 > 440
*Modification (inclusion of Oxygen saturation as variable for respiratory failure)
*Dopamine ≤5 μg/kg min for at least 1 h or Dobutamine (any dose)
**Dopamine > 5 μg/kg min or Epinephrine ≤0,1 μg/kg min or Norepinephrine ≤0,1 μg/kg min
***Dopamine > 15 μg/kg min Epinephrine > 0,1 μg/kg min or Norepinephrine > 0,1 μg/kg min
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